/
Your selections:
Arthritis and tenosynovitis associated with the Anti-PD1 antibody pembrolizumab in metastatic melanoma
- Chan, Matthew M. K., Kefford, Richard F., Carlino, Matteo, Clements, Arthur, Manolios, Nicholas
Antiproliferative effects of continued mitogen-activated protein kinase pathway inhibition following acquired resistance to BRAF and/or MEK inhibition in melanoma
- Carlino, Matteo S., Gowrishankar, Kavitha, Rizos, Helen, Saunders, Catherine A. B., Pupo, Gulietta M., Snoyman, Stephanie, Zhang, Xu Dong, Saw, Robyn, Becker, Therese M., Kefford, Richard F., Long, Georgina V.
A randomized, double-blind, placebo-controlled study of high-dose bosentan in patients with stage IV metastatic melanoma receiving first-line dacarbazine chemotherapy
- Kefford, Richard F., Clingan, Philip R., Brady, Benjamin, Ballmer, Andrea, Morganti, Adele, Hersey, Peter
Are you sure you would like to clear your session, including search history and login status?